Key indicators: single-crystal X-ray study; T = 173 K; mean (C-C) = 0.002 Å; R factor = 0.032; wR factor = 0.081; data-to-parameter ratio = 13.5.
The title compound, C 11 H 13 N 3 O, is a derivative of the antituberculosis drug isoniazid [systematic name: pyridine-4-carbohydrazide]. The crystal structure consists of repeating hydrogen-bonded chains parallel to the b axis. Adjacent molecules in the chains are linked by bifurcated N-HÁ Á Á(O,N) hydrogen bonds, which form an R 1 2 (5) ring motif.
Related literature
For hydrogen-bond motifs, see: Bernstein et al. (1995) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). (Brandenburg, 1999) ; software used to prepare material for publication: WinGX (Farrugia, 1999) and PLATON (Spek, 2009 (Bernstein et al., 1995) hydrogen bonded ring formed with adjacent amide functional groups, leading to a chain along the b-axis.
A stoichiometric amount in the ratio of 1:1 of isonicotinic acid hydrazide (0.200 g, 1.46 mmol) to cyclopentanone (0.129 g) was dissolved in 5 ml of methanol. The solution was refluxed for a few hours, and left to cool to room temperature.
Colourless, block-like crystals were harvested after slow evaporation over a few days at ambient conditions.
Refinement
The C-bound H atoms were geometrically placed (C-H bond lengths of 0.95 (aromatic CH) and 0.99 (methylene CH 2 ) Å) and refined as riding with U iso (H) = 1.2U eq (C). The N-bound H atoms were located in the difference map and coordinates refined freely together with their isotropic thermal parameters. (Farrugia, 1997) and DIAMOND (Brandenburg, 1999) ; software used to prepare material for publication: WinGX (Farrugia, 1999) and PLATON (Spek, 2009 The asymmetric unit of (I) showing the atom numbering scheme. Displacement ellipsoids are shown at the 50% probability level. 
Computing details

